LogoFDA 510(k) Search
Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K093122
    Device Name
    MBCP+
    Manufacturer
    BIOMATLANTE
    Date Cleared
    2010-03-15

    (164 days)

    Product Code
    LYC
    Regulation Number
    872.3930
    Type
    Traditional
    Panel
    Dental
    Reference & Predicate Devices
    K042706,K051443,K051885
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    MBCP+™ is intended for use as a bone grafting material to fill, augment or reconstruct periodontal or bony defects of the oral and maxillofacial region.

    These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone.

    MBCP+™ can be used with autogenous bone grafting materials.

    Typical uses include:

    • Periodontal/Infrabony defects
    • Ridge augmentation
    • Extraction sites (implant preparation/placement)
    • Sinus lifts
    • Cystic cavities
    Device Description

    MBCP+™ is a bone graft material used in dental applications. The MBCP+™ product consists of a biphasic ceramic (e.g hydroxyapatite and tricalcium phosphate beta). MBCP+™ dental product is a synthetic device, available in different sizes of granules. MBCP+™ product is available sterile for single use.

    AI/ML Overview

    This document is a 510(k) premarket notification for a bone grafting material, MBCP+™. It establishes substantial equivalence to previously marketed devices and does not contain information about acceptance criteria or a study proving the device meets said criteria.

    The document primarily focuses on:

    • Device identification: Product name (MBCP+™), classification, product code, and relevant regulations.
    • Intended use: Description of dental applications for which MBCP+™ is intended.
    • Comparison to predicate devices: Stating that it has the same intended use, principle of operation, and similar technological characteristics to listed predicate devices (OsSatura™, Cerasorb™ Dental, MBCP™).
    • Non-clinical performance data: Mentioning that testing was performed according to the "Guidance Class II Special Controls Guidance Document: Dental Bone Grafting Material Devices" to support substantial equivalence.

    Therefore, I cannot provide the requested information regarding acceptance criteria and studies demonstrating that the device meets them, as this specific document does not contain that level of detail. It simply states that non-clinical performance data supports substantial equivalence based on regulatory guidance for dental bone grafting materials. There are no performance metrics, sample sizes, ground truth information, or multi-reader studies described in this filing.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1